BHC
Bausch Health Companies Inc.
Price Chart
Latest Quote
$4.76
-0.20 (-4.03%)
Current Price
| Previous Close | $4.96 |
| Open | $4.97 |
| Day High | $4.99 |
| Day Low | $4.75 |
| Volume | 1,664,088 |
Stock Information
| Shares Outstanding | 373.48M |
| Total Debt | $20.80B |
| Cash Equivalents | $1.30B |
| Revenue | $10.53B |
| Net Income | $-1.21B |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $1.78B |
| EPS (TTM) | $-3.24 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $22.33B |
| Sales | $10.53B |
| Income | $-1.21B |
| Book/sh | $-5.51 |
| Cash/sh | $3.48 |
| Employees | 20K |
Financial Ratios
| Quick Ratio | 0.77 |
| Current Ratio | 1.32 |
Returns & Margins
| ROA | 5.93% |
| Gross Margin | 71.04% |
| Operating Margin | 20.64% |
| Profit Margin | -11.47% |
Ownership
| Insider Ownership | 10.89% |
| Institutional Ownership | 65.13% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 1.13 |
| PEG | 0.01 |
| P/S | 0.17 |
| P/B | -0.86 |
Analyst Data
| Recommendation | hold |
| Target Price | $7.40 |
Technical Indicators
| SMA20 | $5.21 |
| SMA50 | $5.44 |
| SMA200 | $6.13 |
| RSI | 30.06 |
| ATR | 0.2064 |
| Shares Float | 259.97M |
| Short Float | 2.05% |
| Short Ratio | 3.24 |
| Volatility | 0.41 |
| Rel Volume | 0.91 |
Performance History
| Week | -7.57% |
| Month | -10.86% |
| Quarter | -6.48% |
| 6 Months | -31.11% |
| YTD | -33.98% |
| Year | -19.46% |
| 3 Years | -34.71% |
| 5 Years | -84.92% |
| 10 Years | -78.86% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-17 | $4.76 | 1,822,800 |
| 2026-06-16 | $4.96 | 2,142,600 |
| 2026-06-15 | $4.99 | 2,308,600 |
| 2026-06-12 | $5.06 | 1,853,500 |
| 2026-06-11 | $5.16 | 1,441,000 |
| 2026-06-10 | $5.15 | 1,933,500 |
| 2026-06-09 | $5.17 | 1,807,500 |
| 2026-06-08 | $5.11 | 1,855,400 |
| 2026-06-05 | $5.37 | 1,840,500 |
| 2026-06-04 | $5.26 | 3,176,700 |
| 2026-06-03 | $4.95 | 2,580,200 |
| 2026-06-02 | $5.01 | 3,975,000 |
| 2026-06-01 | $5.31 | 1,535,800 |
| 2026-05-29 | $5.36 | 2,525,400 |
| 2026-05-28 | $5.41 | 1,534,200 |
| 2026-05-27 | $5.39 | 1,806,700 |
| 2026-05-26 | $5.40 | 1,295,700 |
| 2026-05-22 | $5.47 | 1,622,400 |
| 2026-05-21 | $5.45 | 1,221,200 |
| 2026-05-20 | $5.50 | 1,876,900 |
| 2026-05-19 | $5.32 | 1,769,000 |
| 2026-05-18 | $5.34 | 781,600 |
About Bausch Health Companies Inc.
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
đ° Latest News
Health Care Roundup: Market Talk
The Wall Street Journal âĸ 2026-06-09T21:06:00Z
Bausch (BHC) Down 5.4% Since Last Earnings Report: Can It Rebound?
Zacks âĸ 2026-05-29T15:30:28Z
Why Bausch Health Companies Was Crawling Higher This Week
Motley Fool âĸ 2026-05-01T05:29:29Z
TSX up 455 Points at Midday With Healthcare, Materials, The Best Performers
MT Newswires âĸ 2026-04-30T16:22:45ZBHC Q1 Earnings Miss Estimates, Sales Grow on Salix & Solta Strength
Zacks âĸ 2026-04-30T14:51:00Z
Bausch Health Companies Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-04-30T12:30:00Z
Bausch Health Companies Inc (BHC) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ...
GuruFocus.com âĸ 2026-04-30T07:18:20ZBausch + Lomb Q1 Earnings Call Highlights
MarketBeat âĸ 2026-04-30T03:40:43Z
Bausch Health Cos Q1 Earnings Call Highlights
MarketBeat âĸ 2026-04-30T03:40:42Z
Bausch Health (BHC) Lags Q1 Earnings Estimates
Zacks âĸ 2026-04-30T00:20:02Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $2,806,000,000 | $2,592,000,000 | $2,372,000,000 | $2,185,000,000 |
| Cost Of Revenue | $3,013,000,000 | $2,782,000,000 | $2,559,000,000 | $2,364,000,000 |
| Total Revenue | $10,266,000,000 | $9,625,000,000 | $8,757,000,000 | $8,124,000,000 |
| Operating Revenue | $10,156,000,000 | $9,518,000,000 | $8,663,000,000 | $8,025,000,000 |
| Expenses | ||||
| Interest Expense | $1,604,000,000 | $1,388,000,000 | $1,328,000,000 | $1,464,000,000 |
| Total Expenses | $8,081,000,000 | $7,771,000,000 | $7,157,000,000 | $6,733,000,000 |
| Other Income Expense | $-262,000,000 | $-332,000,000 | $-688,000,000 | $-70,000,000 |
| Net Non Operating Interest Income Expense | $-1,556,000,000 | $-1,355,000,000 | $-1,302,000,000 | $-1,450,000,000 |
| Interest Expense Non Operating | $1,604,000,000 | $1,388,000,000 | $1,328,000,000 | $1,464,000,000 |
| Operating Expense | $5,068,000,000 | $4,989,000,000 | $4,598,000,000 | $4,369,000,000 |
| Other Non Operating Income Expenses | - | - | $-1,000,000 | $-35,000,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $157,000,000 | $-46,000,000 | $-592,000,000 | $-225,000,000 |
| Net Interest Income | $-1,556,000,000 | $-1,355,000,000 | $-1,302,000,000 | $-1,450,000,000 |
| Interest Income | $48,000,000 | $33,000,000 | $26,000,000 | $14,000,000 |
| Normalized Income | $379,700,000 | $236,200,000 | $-179,800,000 | $-199,173,500 |
| Net Income From Continuing And Discontinued Operation | $157,000,000 | $-46,000,000 | $-592,000,000 | $-225,000,000 |
| Total Operating Income As Reported | $1,813,000,000 | $1,546,000,000 | $963,000,000 | $454,000,000 |
| Net Income Common Stockholders | $157,000,000 | $-46,000,000 | $-592,000,000 | $-225,000,000 |
| Net Income | $157,000,000 | $-46,000,000 | $-592,000,000 | $-225,000,000 |
| Net Income Including Noncontrolling Interests | $120,000,000 | $-72,000,000 | $-611,000,000 | $-212,000,000 |
| Net Income Continuous Operations | $120,000,000 | $-72,000,000 | $-611,000,000 | $-212,000,000 |
| Pretax Income | $367,000,000 | $167,000,000 | $-390,000,000 | $-129,000,000 |
| Special Income Charges | $-210,000,000 | $-285,000,000 | $-635,000,000 | $-27,000,000 |
| Interest Income Non Operating | $48,000,000 | $33,000,000 | $26,000,000 | $14,000,000 |
| Operating Income | $2,185,000,000 | $1,854,000,000 | $1,600,000,000 | $1,391,000,000 |
| Depreciation Amortization Depletion Income Statement | $1,001,000,000 | $1,077,000,000 | $1,077,000,000 | $1,215,000,000 |
| Depreciation And Amortization In Income Statement | $1,001,000,000 | $1,077,000,000 | $1,077,000,000 | $1,215,000,000 |
| Amortization Of Intangibles Income Statement | $1,001,000,000 | $1,077,000,000 | $1,077,000,000 | $1,215,000,000 |
| Gross Profit | $7,253,000,000 | $6,843,000,000 | $6,198,000,000 | $5,760,000,000 |
| Per Share | ||||
| Diluted EPS | $0.42 | $-0.13 | $-1.62 | $-0.62 |
| Basic EPS | $0.42 | $-0.13 | $-1.62 | $-0.62 |
| Other | ||||
| Tax Effect Of Unusual Items | $-39,300,000 | $-49,800,000 | $-274,800,000 | $-9,173,500 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $3,441,000,000 | $3,154,000,000 | $2,889,000,000 | $2,764,000,000 |
| Total Unusual Items | $-262,000,000 | $-332,000,000 | $-687,000,000 | $-35,000,000 |
| Total Unusual Items Excluding Goodwill | $-262,000,000 | $-332,000,000 | $-687,000,000 | $-35,000,000 |
| Reconciled Depreciation | $1,208,000,000 | $1,267,000,000 | $1,264,000,000 | $1,394,000,000 |
| EBITDA (Bullshit earnings) | $3,179,000,000 | $2,822,000,000 | $2,202,000,000 | $2,729,000,000 |
| EBIT | $1,971,000,000 | $1,555,000,000 | $938,000,000 | $1,335,000,000 |
| Diluted Average Shares | $373,809,524 | $353,846,154 | $365,432,099 | $362,903,226 |
| Basic Average Shares | $373,809,524 | $353,846,154 | $365,432,099 | $362,903,226 |
| Diluted NI Availto Com Stockholders | $157,000,000 | $-46,000,000 | $-592,000,000 | $-225,000,000 |
| Minority Interests | $37,000,000 | $26,000,000 | $19,000,000 | $-13,000,000 |
| Tax Provision | $247,000,000 | $239,000,000 | $221,000,000 | $83,000,000 |
| Gain On Sale Of Ppe | $6,000,000 | $10,000,000 | $3,000,000 | $5,000,000 |
| Other Special Charges | $13,000,000 | $215,000,000 | $-54,000,000 | $-875,000,000 |
| Impairment Of Capital Assets | $153,000,000 | $29,000,000 | $547,000,000 | $839,000,000 |
| Restructuring And Mergern Acquisition | $50,000,000 | $51,000,000 | $145,000,000 | $63,000,000 |
| Gain On Sale Of Security | $-52,000,000 | $-47,000,000 | $-52,000,000 | $-8,000,000 |
| Amortization | $1,001,000,000 | $1,077,000,000 | $1,077,000,000 | $1,215,000,000 |
| Research And Development | $629,000,000 | $616,000,000 | $604,000,000 | $529,000,000 |
| Selling General And Administration | $3,438,000,000 | $3,296,000,000 | $2,917,000,000 | $2,625,000,000 |
| Write Off | - | - | $54,000,000 | $15,000,000 |
Fetched: 2026-06-15
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-16,468,000,000 | $-17,917,000,000 | $-18,661,000,000 | $-18,039,000,000 |
| Total Assets | $26,366,000,000 | $26,523,000,000 | $27,350,000,000 | $25,686,000,000 |
| Total Non Current Assets | $20,209,000,000 | $20,749,000,000 | $21,754,000,000 | $21,439,000,000 |
| Other Non Current Assets | $378,000,000 | $363,000,000 | $307,000,000 | $326,000,000 |
| Non Current Deferred Assets | $1,843,000,000 | $1,968,000,000 | $2,101,000,000 | $2,166,000,000 |
| Non Current Deferred Taxes Assets | $1,843,000,000 | $1,968,000,000 | $2,101,000,000 | $2,166,000,000 |
| Goodwill And Other Intangible Assets | $15,914,000,000 | $16,638,000,000 | $17,639,000,000 | $17,347,000,000 |
| Other Intangible Assets | $4,643,000,000 | $5,551,000,000 | $6,456,000,000 | $5,800,000,000 |
| Current Assets | $6,157,000,000 | $5,774,000,000 | $5,596,000,000 | $4,247,000,000 |
| Other Current Assets | $852,000,000 | $838,000,000 | $1,092,000,000 | $776,000,000 |
| Restricted Cash | $16,000,000 | $20,000,000 | $15,000,000 | $27,000,000 |
| Inventory | $1,629,000,000 | $1,595,000,000 | $1,544,000,000 | $1,090,000,000 |
| Receivables | $2,351,000,000 | $2,140,000,000 | $1,998,000,000 | $1,790,000,000 |
| Accounts Receivable | $2,351,000,000 | $2,140,000,000 | $1,998,000,000 | $1,790,000,000 |
| Allowance For Doubtful Accounts Receivable | $-31,000,000 | $-30,000,000 | $-34,000,000 | $-33,000,000 |
| Gross Accounts Receivable | $2,382,000,000 | $2,170,000,000 | $2,032,000,000 | $1,823,000,000 |
| Cash Cash Equivalents And Short Term Investments | $1,309,000,000 | $1,181,000,000 | $947,000,000 | $564,000,000 |
| Cash And Cash Equivalents | $1,309,000,000 | $1,181,000,000 | $947,000,000 | $564,000,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $19,508,000,000 | $20,435,000,000 | $21,441,000,000 | $20,202,000,000 |
| Total Debt | $20,851,000,000 | $21,616,000,000 | $22,388,000,000 | $20,766,000,000 |
| Long Term Debt And Capital Lease Obligation | $20,615,000,000 | $18,942,000,000 | $21,938,000,000 | $20,334,000,000 |
| Long Term Debt | $20,592,000,000 | $18,942,000,000 | $21,938,000,000 | $20,334,000,000 |
| Current Debt And Capital Lease Obligation | $236,000,000 | $2,674,000,000 | $450,000,000 | $432,000,000 |
| Current Debt | $225,000,000 | $2,674,000,000 | $450,000,000 | $432,000,000 |
| Other Current Borrowings | $225,000,000 | $2,674,000,000 | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $25,989,000,000 | $26,845,000,000 | $27,432,000,000 | $25,426,000,000 |
| Total Non Current Liabilities Net Minority Interest | $21,809,000,000 | $20,093,000,000 | $23,130,000,000 | $21,485,000,000 |
| Other Non Current Liabilities | $1,047,000,000 | $1,023,000,000 | $1,029,000,000 | $949,000,000 |
| Non Current Deferred Liabilities | $147,000,000 | $128,000,000 | $163,000,000 | $202,000,000 |
| Non Current Deferred Taxes Liabilities | $147,000,000 | $128,000,000 | $163,000,000 | $202,000,000 |
| Current Liabilities | $4,180,000,000 | $6,752,000,000 | $4,302,000,000 | $3,941,000,000 |
| Other Current Liabilities | $999,000,000 | $1,104,000,000 | $1,041,000,000 | $1,040,000,000 |
| Payables And Accrued Expenses | $2,560,000,000 | $2,626,000,000 | $2,451,000,000 | $2,169,000,000 |
| Interest Payable | $253,000,000 | $217,000,000 | $236,000,000 | $208,000,000 |
| Payables | $638,000,000 | $652,000,000 | $766,000,000 | $551,000,000 |
| Total Tax Payable | $38,000,000 | $63,000,000 | $47,000,000 | $30,000,000 |
| Income Tax Payable | $38,000,000 | $63,000,000 | $47,000,000 | $30,000,000 |
| Accounts Payable | $600,000,000 | $589,000,000 | $719,000,000 | $521,000,000 |
| Equity | ||||
| Common Stock Equity | $-554,000,000 | $-1,279,000,000 | $-1,022,000,000 | $-692,000,000 |
| Total Equity Gross Minority Interest | $377,000,000 | $-322,000,000 | $-82,000,000 | $260,000,000 |
| Stockholders Equity | $-554,000,000 | $-1,279,000,000 | $-1,022,000,000 | $-692,000,000 |
| Gains Losses Not Affecting Retained Earnings | $-1,760,000,000 | $-2,179,000,000 | $-1,881,000,000 | $-2,056,000,000 |
| Retained Earnings | $-9,667,000,000 | $-9,824,000,000 | $-9,778,000,000 | $-9,186,000,000 |
| Other | ||||
| Ordinary Shares Number | $370,531,987 | $367,843,058 | $365,238,917 | $361,898,846 |
| Share Issued | $370,531,987 | $367,843,058 | $365,238,917 | $361,898,846 |
| Tangible Book Value | $-16,468,000,000 | $-17,917,000,000 | $-18,661,000,000 | $-18,039,000,000 |
| Invested Capital | $20,263,000,000 | $20,337,000,000 | $21,366,000,000 | $20,074,000,000 |
| Working Capital | $1,977,000,000 | $-978,000,000 | $1,294,000,000 | $306,000,000 |
| Capital Lease Obligations | $34,000,000 | $0 | - | - |
| Total Capitalization | $20,038,000,000 | $17,663,000,000 | $20,916,000,000 | $19,642,000,000 |
| Minority Interest | $931,000,000 | $957,000,000 | $940,000,000 | $952,000,000 |
| Additional Paid In Capital | $357,000,000 | $234,000,000 | $214,000,000 | $159,000,000 |
| Capital Stock | $10,516,000,000 | $10,490,000,000 | $10,423,000,000 | $10,391,000,000 |
| Common Stock | $10,516,000,000 | $10,490,000,000 | $10,423,000,000 | $10,391,000,000 |
| Long Term Capital Lease Obligation | $23,000,000 | $0 | - | - |
| Current Capital Lease Obligation | $11,000,000 | $0 | - | - |
| Pensionand Other Post Retirement Benefit Plans Current | $385,000,000 | $348,000,000 | $360,000,000 | $300,000,000 |
| Current Accrued Expenses | $1,922,000,000 | $1,974,000,000 | $1,685,000,000 | $1,618,000,000 |
| Goodwill | $11,271,000,000 | $11,087,000,000 | $11,183,000,000 | $11,547,000,000 |
| Net PPE | $2,074,000,000 | $1,780,000,000 | $1,707,000,000 | $1,600,000,000 |
| Accumulated Depreciation | $-2,424,000,000 | $-2,144,000,000 | $-2,083,000,000 | $-1,920,000,000 |
| Gross PPE | $4,498,000,000 | $3,924,000,000 | $3,790,000,000 | $3,520,000,000 |
| Leases | $396,000,000 | $362,000,000 | $355,000,000 | $342,000,000 |
| Construction In Progress | $569,000,000 | $508,000,000 | $401,000,000 | $280,000,000 |
| Other Properties | $112,000,000 | $97,000,000 | $84,000,000 | $78,000,000 |
| Machinery Furniture Equipment | $2,386,000,000 | $2,071,000,000 | $2,053,000,000 | $1,951,000,000 |
| Buildings And Improvements | $962,000,000 | $817,000,000 | $823,000,000 | $798,000,000 |
| Land And Improvements | $73,000,000 | $69,000,000 | $74,000,000 | $71,000,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $963,000,000 | $947,000,000 | $911,000,000 | $666,000,000 |
| Work In Process | $102,000,000 | $108,000,000 | $124,000,000 | $98,000,000 |
| Raw Materials | $564,000,000 | $540,000,000 | $509,000,000 | $326,000,000 |
| Treasury Shares Number | - | - | $0 | - |
Fetched: 2026-06-15
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $993,000,000 | $1,257,000,000 | $760,000,000 | $-996,000,000 |
| Operating Activities | ||||
| Operating Cash Flow | $1,400,000,000 | $1,597,000,000 | $1,032,000,000 | $-728,000,000 |
| Cash Flow From Continuing Operating Activities | $1,400,000,000 | $1,597,000,000 | $1,032,000,000 | $-728,000,000 |
| Operating Gains Losses | $-189,000,000 | $-43,000,000 | $24,000,000 | $-883,000,000 |
| Investing Activities | ||||
| Capital Expenditure | $-407,000,000 | $-340,000,000 | $-272,000,000 | $-268,000,000 |
| Investing Cash Flow | $-595,000,000 | $-454,000,000 | $-2,145,000,000 | $-303,000,000 |
| Cash Flow From Continuing Investing Activities | $-595,000,000 | $-454,000,000 | $-2,145,000,000 | $-303,000,000 |
| Net Other Investing Changes | $7,000,000 | $7,000,000 | $5,000,000 | $5,000,000 |
| Financing Activities | ||||
| Financing Cash Flow | $-742,000,000 | $-868,000,000 | $1,475,000,000 | $-474,000,000 |
| Cash Flow From Continuing Financing Activities | $-742,000,000 | $-868,000,000 | $1,475,000,000 | $-474,000,000 |
| Net Other Financing Charges | $-105,000,000 | $-69,000,000 | $-106,000,000 | $-139,000,000 |
| Issuance Of Capital Stock | - | $0 | $0 | $675,000,000 |
| Net Common Stock Issuance | - | $0 | $0 | $675,000,000 |
| Common Stock Issuance | - | $0 | $0 | $675,000,000 |
| Other | ||||
| Repayment Of Debt | $-11,191,000,000 | $-1,460,000,000 | $-1,710,000,000 | $-7,846,000,000 |
| Issuance Of Debt | $10,554,000,000 | $661,000,000 | $3,291,000,000 | $6,836,000,000 |
| Interest Paid Supplemental Data | $1,810,000,000 | $1,674,000,000 | $1,533,000,000 | $1,540,000,000 |
| Income Tax Paid Supplemental Data | $163,000,000 | $61,000,000 | $237,000,000 | $266,000,000 |
| End Cash Position | $1,325,000,000 | $1,201,000,000 | $962,000,000 | $591,000,000 |
| Beginning Cash Position | $1,201,000,000 | $962,000,000 | $591,000,000 | $2,119,000,000 |
| Effect Of Exchange Rate Changes | $61,000,000 | $-36,000,000 | $9,000,000 | $-23,000,000 |
| Changes In Cash | $63,000,000 | $275,000,000 | $362,000,000 | $-1,505,000,000 |
| Net Issuance Payments Of Debt | $-637,000,000 | $-799,000,000 | $1,581,000,000 | $-1,010,000,000 |
| Net Long Term Debt Issuance | $-637,000,000 | $-799,000,000 | $1,581,000,000 | $-1,010,000,000 |
| Long Term Debt Payments | $-11,191,000,000 | $-1,460,000,000 | $-1,710,000,000 | $-7,846,000,000 |
| Long Term Debt Issuance | $10,554,000,000 | $661,000,000 | $3,291,000,000 | $6,836,000,000 |
| Interest Received Cfi | $12,000,000 | $13,000,000 | $13,000,000 | $0 |
| Net Investment Purchase And Sale | $-3,000,000 | $2,000,000 | $-1,000,000 | $5,000,000 |
| Sale Of Investment | $8,000,000 | $14,000,000 | $26,000,000 | $22,000,000 |
| Purchase Of Investment | $-11,000,000 | $-12,000,000 | $-27,000,000 | $-17,000,000 |
| Net Business Purchase And Sale | $-204,000,000 | $-136,000,000 | $-1,890,000,000 | $-45,000,000 |
| Purchase Of Business | $-204,000,000 | $-136,000,000 | $-1,890,000,000 | $-45,000,000 |
| Net Intangibles Purchase And Sale | $-10,000,000 | $-3,000,000 | $-57,000,000 | $-50,000,000 |
| Purchase Of Intangibles | $-10,000,000 | $-3,000,000 | $-57,000,000 | $-50,000,000 |
| Net PPE Purchase And Sale | $-397,000,000 | $-337,000,000 | $-215,000,000 | $-218,000,000 |
| Purchase Of PPE | $-397,000,000 | $-337,000,000 | $-215,000,000 | $-218,000,000 |
| Change In Working Capital | $-219,000,000 | $7,000,000 | $-582,000,000 | $-396,000,000 |
| Change In Payables And Accrued Expense | $-76,000,000 | $357,000,000 | $158,000,000 | $-75,000,000 |
| Change In Payable | $-76,000,000 | $357,000,000 | $158,000,000 | $-75,000,000 |
| Change In Account Payable | $-76,000,000 | $357,000,000 | $158,000,000 | $-75,000,000 |
| Change In Prepaid Assets | $3,000,000 | $133,000,000 | $-223,000,000 | $-66,000,000 |
| Change In Inventory | $-12,000,000 | $-267,000,000 | $-322,000,000 | $-198,000,000 |
| Change In Receivables | $-134,000,000 | $-216,000,000 | $-195,000,000 | $-57,000,000 |
| Changes In Account Receivables | $-134,000,000 | $-216,000,000 | $-195,000,000 | $-57,000,000 |
| Other Non Cash Items | $-40,000,000 | $131,000,000 | $151,000,000 | $-1,471,000,000 |
| Stock Based Compensation | $216,000,000 | $150,000,000 | $132,000,000 | $126,000,000 |
| Provisionand Write Offof Assets | $71,000,000 | $62,000,000 | $56,000,000 | $51,000,000 |
| Asset Impairment Charge | $153,000,000 | $29,000,000 | $547,000,000 | $839,000,000 |
| Deferred Tax | $80,000,000 | $66,000,000 | $51,000,000 | $-176,000,000 |
| Deferred Income Tax | $80,000,000 | $66,000,000 | $51,000,000 | $-176,000,000 |
| Depreciation Amortization Depletion | $1,208,000,000 | $1,267,000,000 | $1,264,000,000 | $1,394,000,000 |
| Depreciation And Amortization | $1,208,000,000 | $1,267,000,000 | $1,264,000,000 | $1,394,000,000 |
| Amortization Cash Flow | $1,208,000,000 | $1,267,000,000 | $1,264,000,000 | $1,394,000,000 |
| Amortization Of Intangibles | $1,208,000,000 | $1,267,000,000 | $1,264,000,000 | $1,394,000,000 |
| Gain Loss On Investment Securities | $-10,000,000 | $-13,000,000 | $-13,000,000 | $-6,000,000 |
| Net Foreign Currency Exchange Gain Loss | $-11,000,000 | $3,000,000 | $41,000,000 | $3,000,000 |
| Net Income From Continuing Operations | $120,000,000 | $-72,000,000 | $-611,000,000 | $-212,000,000 |
| Net Short Term Debt Issuance | - | - | - | - |
| Short Term Debt Payments | - | - | - | - |
| Short Term Debt Issuance | - | - | - | - |
Fetched: 2026-06-15